Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.2%

3 terminated/withdrawn out of 136 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

10%

13 trials in Phase 3/4

Results Transparency

6%

2 of 36 completed trials have results

Key Signals

31 recruiting2 with results

Enrollment Performance

Analytics

N/A
57(64.0%)
Phase 2
17(19.1%)
Phase 4
9(10.1%)
Phase 3
4(4.5%)
Phase 1
1(1.1%)
Early Phase 1
1(1.1%)
89Total
N/A(57)
Phase 2(17)
Phase 4(9)
Phase 3(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (136)

Showing 20 of 136 trials
NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT04078568Phase 3Completed

Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease

Role: collaborator

NCT07202559Not ApplicableRecruiting

Indometacin With or Without Aggressive Intravenous Hydration to Prevent Pancreatitis After Pancreatic Extracorporeal Shock Wave Lithotripsy

Role: collaborator

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: lead

NCT07390981Not ApplicableNot Yet Recruiting

Intradermal Acupuncture for Assisting SSRI Dose Reduction in Major Depressive Disorder

Role: lead

NCT05620095Recruiting

Durg Coated Balloon Angioplasty in Infrapopliteal Lesions

Role: collaborator

NCT04801004Completed

A Real-world Study to Evaluate the Primary Patency and Freedom From TLR of Endovascular Treatment in TOSAKA III In-stent Restenosis of Lower Extremity Femoropopliteal Artery.

Role: collaborator

NCT05387031Recruiting

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

Role: collaborator

NCT06124768Recruiting

Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

Role: collaborator

NCT04698304Active Not Recruiting

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Role: collaborator

NCT06164561Recruiting

18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Role: collaborator

NCT06643247Not ApplicableRecruiting

Electroacupuncture Regulation of Immune Cells in Herpes Zoster

Role: lead

NCT07306247Not ApplicableNot Yet Recruiting

Multicenter Prospective Non-randomized Controlled Study of ALA-PDT for LSIL With HPV16/18 Infection

Role: collaborator

NCT07306260Not ApplicableNot Yet Recruiting

Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2

Role: collaborator

NCT07266168Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Role: collaborator

NCT05171842Completed

Dissection of the Superior Mesenteric Artery

Role: collaborator

NCT06526429Not ApplicableCompleted

Local Ischemic Postconditioning in Acute Ischemic Stroke

Role: collaborator

NCT07242443Phase 4Not Yet Recruiting

Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication(Frequency Adjusted Same-dose Therapy for H. Pylori)

Role: lead

NCT07242456Phase 2Recruiting

Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication

Role: lead

NCT07207278Recruiting

Multi Omics Molecular Characteristics and Immunophenotyping of Lung Signet Ring Cell Carcinoma

Role: lead